# The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

> **NCT06666504** · — · NOT_YET_RECRUITING · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 150 (estimated)

## Conditions studied

- Severe Asthma

## Interventions

- **OTHER:** Combined Retrospective and Prospective Data Analysis

## Key facts

- **NCT ID:** NCT06666504
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06666504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06666504, "The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT06666504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*